/Investor DB

Lifeforce Capital — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Notable Labsnotablelabs.comin𝕏Series A · Sep 2017 · $10M

Notable Labs operates a personalized drug discovery platform that tests combinations of FDA-approved drugs against a patient's own cancer cells to identify treatment options, focusing initially on relapsed and refractory blood cancer.

AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US

Matthew De Silva(CEO)inPete Quinzio(Founder)inConnor Warnock(Senior Engineer)Van Duesterberg(Science Consultant)Omid Karkouti(Vice President of Business Development)Scott Patterson(Vice President of Engineering)

Co-investors11.2 CapitalAlumni VenturesBuilders VCFunders Club ManagementFundersClubGaingels+31 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.